Natasha M. Kafai

发表

Potently neutralizing and protective human antibodies against SARS-CoV-2

Lisa E. Gralinski, Larissa B. Thackray, Benjamin K. Mueller, 2020, Nature.

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

Larissa B. Thackray, D. Fremont, M. Diamond, 2020, The Journal of Immunology.

LDLRAD3 is a receptor for Venezuelan equine encephalitis virus

Larissa B. Thackray, C. Nelson, D. Fremont, 2020, Nature.

Rickettsia Sca4 Reduces Vinculin-Mediated Intercellular Tension to Promote Spread

J. Theriot, Rebecca L. Lamason, M. Welch, 2016, Cell.

Rickettsia Sca 4 Reduces Vinculin-Mediated Intercellular Tension to Promote Spread Graphical

Juan Carlos del Alamo, J. Theriot, Rebecca L. Lamason, 2016 .

Suppression of drug resistance reveals a genetic mechanism of metabolic plasticity in malaria parasites

E. F. Merino, Natasha M. Kafai, Aakash Y. Gandhi, 2018 .

Suppression of Drug Resistance Reveals a Genetic Mechanism of Metabolic Plasticity in Malaria Parasites

Natasha M. Kafai, Aakash Y. Gandhi, Ann M. Guggisberg, 2018, mBio.

A streamlined method for transposon mutagenesis of Rickettsia parkeri yields numerous mutations that impact infection

Rebecca L. Lamason, M. Welch, Natasha M. Kafai, 2018, bioRxiv.

Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in mice

D. Baker, M. Diamond, Inna Goreshnik, 2021, bioRxiv.

The Antigenic Anatomy of SARS-CoV-2 Receptor Binding Domain

D. Stuart, P. Klenerman, J. Knight, 2020, SSRN Electronic Journal.

Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

Shamus P. Keeler, M. Diamond, M. Holtzman, 2020, Nature Immunology.

Malaria in Children

Natasha M. Kafai, A. O. Odom John, Audrey R. Odom John, 2017, Infectious Disease Clinics of North America.

Entry receptors — the gateway to alphavirus infection

M. Diamond, Natasha M. Kafai, O. Zimmerman, 2023, The Journal of clinical investigation.

Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals

Lisa E. Gralinski, Larissa B. Thackray, Samuel B. Day, 2020, bioRxiv.

Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope

D. Fremont, M. Diamond, M. Gross, 2021, Cell.

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

Lisa E. Gralinski, Shamus P. Keeler, D. Fremont, 2020, Cell.

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies

Larissa B. Thackray, Shamus P. Keeler, D. Fremont, 2020, Cell.

SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function

Shamus P. Keeler, M. Diamond, M. Holtzman, 2020, Nature Immunology.

Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge

Soila Sukupolvi-Petty, M. Diamond, J. Crowe, 2022, The Journal of experimental medicine.

Genome-Wide siRNA Screen Identifies Complementary Signaling Pathways Involved in Listeria Infection and Reveals Different Actin Nucleation Mechanisms during Listeria Cell Invasion and Actin Comet Tail Formation

P. Cossart, C. Dehio, Andreas Kühbacher, 2015, mBio.

Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice

Shamus P. Keeler, D. Fremont, M. Diamond, 2020, Cell Host & Microbe.

Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis

Shamus P. Keeler, D. Fremont, M. Diamond, 2020, bioRxiv.

The antigenic anatomy of SARS-CoV-2 receptor binding domain

D. Stuart, P. Klenerman, J. Knight, 2021, Cell.

Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice

Wadim L. Matochko, Benjamin S. Freedman, M. Diamond, 2022, Science Translational Medicine.

A single intranasal dose of chimpanzee adenovirus-vectored vaccine confers sterilizing immunity against SARS-CoV-2 infection

Lisa E. Gralinski, Shamus P. Keeler, D. Fremont, 2020, bioRxiv.

Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses

C. Nelson, D. Fremont, T. Pierson, 2021, The Journal of experimental medicine.

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

Larissa B. Thackray, M. Diamond, S. Elbashir, 2021, Science Translational Medicine.

Multivalent designed proteins protect against SARS-CoV-2 variants of concern

Wadim L. Matochko, Benjamin S. Freedman, D. Baker, 2021, bioRxiv.

LDLRAD3 is a receptor for Venezuelan equine encephalitis virus

Larissa B. Thackray, C. Nelson, D. Fremont, 2020, Nature.

Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor

C. Nelson, D. Fremont, M. Diamond, 2021, Nature.

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

Larissa B. Thackray, M. Diamond, S. Elbashir, 2021, bioRxiv.

Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease

D. Baker, M. Diamond, Inna Goreshnik, 2021, Cell Host & Microbe.

SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function

Shamus P. Keeler, M. Diamond, M. Holtzman, 2020, bioRxiv.

Entry receptor LDLRAD3 is required for Venezuelan equine encephalitis virus peripheral infection and neurotropism leading to pathogenesis in mice

M. Diamond, R. Klein, Y. Alippe, 2023, Cell reports.

The low-density lipoprotein receptor promotes infection of multiple encephalitic alphaviruses

D. Fremont, Natasha M. Kafai, Hongming Ma, 2024, Nature communications.